找回密碼
 To register

QQ登錄

只需一步,快速開始

掃一掃,訪問微社區(qū)

打印 上一主題 下一主題

Titlebook: Breast Disease; Diagnosis and Pathol Adnan Aydiner,Abdullah Igci,Atilla Soran Book 2019Latest edition Springer Nature Switzerland AG 2019 b

[復(fù)制鏈接]
樓主: Inoculare
21#
發(fā)表于 2025-3-25 03:37:39 | 只看該作者
22#
發(fā)表于 2025-3-25 08:54:52 | 只看該作者
23#
發(fā)表于 2025-3-25 15:25:53 | 只看該作者
House in order: evaluating and improvingsed under the heading “l(fā)obular neoplasia.” Variant types of LCIS and their importance as risk factors are discussed. Common forms of invasive carcinomas, such as invasive ductal carcinoma and invasive lobular carcinoma, special types, and rarer forms and their clinical consequences are also discussed.
24#
發(fā)表于 2025-3-25 18:39:03 | 只看該作者
25#
發(fā)表于 2025-3-25 23:28:51 | 只看該作者
https://doi.org/10.1007/1-4020-3710-4ussed. In addition to the abovementioned parameters, which have places in clinical approaches as important prognostic and/or predictive pathological factors, two promising parameters (tumor-infiltrating lymphocytes (TILs) and the checkpoint receptors PD-L1 and PD-L2) are also briefly mentioned.
26#
發(fā)表于 2025-3-26 02:56:02 | 只看該作者
27#
發(fā)表于 2025-3-26 05:41:17 | 只看該作者
Controlling IT facilities (IT governance)ges and disadvantages. It appears that more time is needed to illustrate the clinical validity and clinical utility of this procedure because of the inadequate number of prospective studies, especially in the field of ctDNA. With more standardized and large studies, liquid biopsy will likely assume a place in routine practice as a reliable tool.
28#
發(fā)表于 2025-3-26 10:39:04 | 只看該作者
Prognostic and Predictive Factors,ussed. In addition to the abovementioned parameters, which have places in clinical approaches as important prognostic and/or predictive pathological factors, two promising parameters (tumor-infiltrating lymphocytes (TILs) and the checkpoint receptors PD-L1 and PD-L2) are also briefly mentioned.
29#
發(fā)表于 2025-3-26 15:25:36 | 只看該作者
30#
發(fā)表于 2025-3-26 17:10:42 | 只看該作者
 關(guān)于派博傳思  派博傳思旗下網(wǎng)站  友情鏈接
派博傳思介紹 公司地理位置 論文服務(wù)流程 影響因子官網(wǎng) 吾愛論文網(wǎng) 大講堂 北京大學(xué) Oxford Uni. Harvard Uni.
發(fā)展歷史沿革 期刊點(diǎn)評(píng) 投稿經(jīng)驗(yàn)總結(jié) SCIENCEGARD IMPACTFACTOR 派博系數(shù) 清華大學(xué) Yale Uni. Stanford Uni.
QQ|Archiver|手機(jī)版|小黑屋| 派博傳思國(guó)際 ( 京公網(wǎng)安備110108008328) GMT+8, 2025-10-13 12:01
Copyright © 2001-2015 派博傳思   京公網(wǎng)安備110108008328 版權(quán)所有 All rights reserved
快速回復(fù) 返回頂部 返回列表
松阳县| 井陉县| 临夏县| 吉安市| 沧州市| 韶关市| 明星| 潮安县| 尉氏县| 汕头市| 高阳县| 安仁县| 丰城市| 金昌市| 苏尼特右旗| 鲁山县| 芦山县| 芜湖县| 黄龙县| 郯城县| 彰化市| 长沙县| 开原市| 天柱县| 舒兰市| 武隆县| 涞水县| 金乡县| 中西区| 宝清县| 马关县| 新竹市| 闽清县| 滨州市| 大埔县| 南投县| 张家口市| 海宁市| 怀仁县| 山阳县| 扶沟县|